Although the benefits in reduction of thromboembolic events in subgroup analysis by follow-up period showed conflicting results, it also suggests a clear trend of an appealing effectiveness profile for NOACs in comparison with warfarin in the present study.
← all excerpts
Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation and Previous Stroke: A Systematic Review and Meta-Analysis.
1
—
—